65517

You are here

Hypofractionation: Is Less Better?

A subscription to the 2012 Genitourinary Cancers Symposium is required to view presentations in this session Subscription Information

Video

General Session

Chair(s):

Jason Alexander Efstathiou, MD, DPhil;

Jeff M. Michalski, MD;

Prostate Cancer Track 2012 Genitourinary Cancers Symposium

General Session I: Radiation Therapy in the Management of Early-to-Intermediate-Risk Prostate Cancer

W. Robert Lee, MD
Speaker

» Listen (Right-click to download audio)

A subscription to the 2012 Genitourinary Cancers Symposium is required to view presentations in this session Subscription Information

More by W. Robert Lee :

Abstracts

Methylation RE in serum of patients with breast cancer and relation with molecular phenotype and worse prognostic factors.

Meeting: 2011 Breast Cancer Symposium
Abstract No: 224
First Author: J. Martínez-Galan
Category: Prevention Survivorship & Health Policy - Molecular Biology
The prognostic value of hypermethilation 14-3-3 sigma promoter in breast cancer patients.

Meeting: 2011 ASCO Annual Meeting
Abstract No: e13577
First Author: J. Martínez-Galan
Category: Developmental Therapeutics - Experimental Therapeutics - Epigenetics

Virtual Meeting Presentations

Epigenetic aspects of triple-negative in patients with breast cancer.

Meeting: 2012 ASCO Annual Meeting
Session: Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy(General Poster Session)
Presenter: Joaquina Martínez-Galan
Aberrant methylation in breast cancer and correlates with tumor phenotypes, prognostic factors, and patient outcome.

Meeting: 2010 Breast Cancer Symposium
Session: General Poster Session C(General Poster Session)
Presenter: Joaquina Martínez-Galan

Educational Book Manuscripts